Martin Schiller

Martin Schiller is the Chairman and CEO at Heligenics. Prior to joining Heligenics, they were an Assistant and Associate Professor at the University of Nevada Las Vegas from August 2000 to July 2009. Dr. Schiller's research focuses on the secretory pathway, prohormone processing and brain tumors. Martin received their MD from Johns Hopkins School of Medicine in 1997 and completed their residency in Anesthesiology at the University of Connecticut Health Center in 2000.

Martin Schiller earned their BS in biochemistry from Hofstra University. Martin then went on to earn their Doctor of Philosophy (Ph.D.) in biochemistry from Utah State University. After completing their Ph.D., they became a postdoctoral fellow in neuroscience at The Johns Hopkins University School of Medicine.

Lancer Brown - Senior Molecular Biologist, Liz Valente - Senior Cell Culture Technologist report to Martin Schiller.